MUROMACHI CHEMICALS INC. 4885Short Interest
No institution currently reports a short position of 0.5% or more in MUROMACHI CHEMICALS INC. (4885). The last disclosure was on 2026-10-16 (GOLDMAN SACHS INTERNATIONAL, 0.39%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
305 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 9 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2021-02-26 |
|---|---|
| Latest disclosure | 2026-10-16 (GOLDMAN SACHS INTERNATIONAL, 0.39%) |
| Reporting institutions | 10 firms (305 reports) |
| Peak estimated short interest | 6.27% (2021-03-04, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- JPM Securities Japan Co Ltd.
- Morgan Stanley MUFG Securities Co., Ltd.
- MERRILL LYNCH INTERNATIONAL
- Credit Suisse AG
- GOLDMAN SACHS INTERNATIONAL
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2025-02-14 | JPM Securities Japan Co Ltd. | Position 20,100 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-07-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 20,400 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2022-05-27 | Credit Suisse AG | Position 20,200 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2025-01-15 | UBS AG | Position 20,100 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2022-11-01 | MERRILL LYNCH INTERNATIONAL | Position 18,600 shares | Ratio 0.45% | ▼0.05% | Below 0.5% |
| 2026-10-16 | GOLDMAN SACHS INTERNATIONAL | Position 16,300 shares | Ratio 0.39% | ▼0.20% | Below 0.5% |
| 2021-05-06 | R Squared Limited | Position 10,200 shares | Ratio 0.38% | ▼0.20% | Below 0.5% |
| 2025-01-15 | Individual | Position 14,600 shares | Ratio 0.35% | ▼0.17% | Below 0.5% |
| 2026-03-03 | Nomura International plc | Position 2,500 shares | Ratio 0.06% | ▼0.45% | Below 0.5% |
| 2021-03-24 | Nomura Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼5.69% | Closed |
Disclosure History 305 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-10-16 | GOLDMAN SACHS INTERNATIONAL | Position 16,300 shares | Ratio 0.39% | ▼0.20% | Below 0.5% |
| 2026-10-06 | GOLDMAN SACHS INTERNATIONAL | Position 24,500 shares | Ratio 0.59% | ▼0.09% | — |
| 2026-09-29 | GOLDMAN SACHS INTERNATIONAL | Position 28,000 shares | Ratio 0.68% | ▼0.02% | — |
| 2026-07-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 20,400 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-08 | Morgan Stanley MUFG Securities Co., Ltd. | Position 20,700 shares | Ratio 0.50% | ▲0.01% | — |
| 2026-07-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 20,400 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-02 | Morgan Stanley MUFG Securities Co., Ltd. | Position 20,500 shares | Ratio 0.50% | ▲0.02% | — |
| 2026-06-11 | GOLDMAN SACHS INTERNATIONAL | Position 28,700 shares | Ratio 0.70% | ▲0.05% | — |
| 2026-06-10 | Morgan Stanley MUFG Securities Co., Ltd. | Position 19,900 shares | Ratio 0.48% | ▼0.08% | Below 0.5% |
| 2026-05-28 | Morgan Stanley MUFG Securities Co., Ltd. | Position 23,100 shares | Ratio 0.56% | ▲0.11% | — |
| 2026-05-27 | Morgan Stanley MUFG Securities Co., Ltd. | Position 18,800 shares | Ratio 0.45% | ▼0.07% | Below 0.5% |
| 2026-04-30 | Morgan Stanley MUFG Securities Co., Ltd. | Position 21,700 shares | Ratio 0.52% | ▲0.03% | — |
| 2026-04-28 | Morgan Stanley MUFG Securities Co., Ltd. | Position 20,300 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-04-27 | Morgan Stanley MUFG Securities Co., Ltd. | Position 21,100 shares | Ratio 0.51% | ▲0.05% | — |
| 2026-04-20 | Morgan Stanley MUFG Securities Co., Ltd. | Position 19,100 shares | Ratio 0.46% | ▼0.11% | Below 0.5% |
| 2026-04-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 23,600 shares | Ratio 0.57% | ▲0.18% | — |
| 2026-04-15 | GOLDMAN SACHS INTERNATIONAL | Position 26,700 shares | Ratio 0.65% | ▲0.24% | — |
| 2026-03-10 | GOLDMAN SACHS INTERNATIONAL | Position 19,800 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2026-03-05 | GOLDMAN SACHS INTERNATIONAL | Position 24,500 shares | Ratio 0.59% | ▼0.20% | — |
| 2026-03-04 | GOLDMAN SACHS INTERNATIONAL | Position 32,500 shares | Ratio 0.79% | ▲0.14% | — |
| 2026-03-03 | Nomura International plc | Position 2,500 shares | Ratio 0.06% | ▼0.45% | Below 0.5% |
| 2026-03-02 | Nomura International plc | Position 21,100 shares | Ratio 0.51% | ▲0.03% | — |
| 2026-02-27 | Nomura International plc | Position 20,000 shares | Ratio 0.48% | ▼0.08% | Below 0.5% |
| 2026-02-20 | Nomura International plc | Position 23,200 shares | Ratio 0.56% | ▲0.07% | — |
| 2026-02-20 | GOLDMAN SACHS INTERNATIONAL | Position 27,000 shares | Ratio 0.65% | ▲0.09% | — |
| 2026-02-18 | Nomura International plc | Position 20,100 shares | Ratio 0.49% | ▼0.18% | Below 0.5% |
| 2026-02-17 | Nomura International plc | Position 27,500 shares | Ratio 0.67% | ▲0.61% | — |
| 2026-02-17 | GOLDMAN SACHS INTERNATIONAL | Position 23,100 shares | Ratio 0.56% | ▲0.14% | — |
| 2026-02-13 | Nomura International plc | Position 9,000 shares | Ratio 0.21% | ▼0.37% | Below 0.5% |
| 2026-02-12 | Nomura International plc | Position 24,000 shares | Ratio 0.58% | ▼0.09% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| CellSource Co.,Ltd.4880 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| FunPep Company Limited4881 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Perseus Proteomics Inc.4882 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Modalis Therapeutics Corporation4883 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kringle Pharma,Inc.4884 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ASKA Pharmaceutical Holdings Co.,Ltd.4886 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| SAWAI GROUP HOLDINGS Co.,Ltd.4887 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| STELLA PHARMA CORPORATION4888 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Renascience Inc.4889 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Tsubota Laboratory Incorporated4890 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |